---
pmid: '18772112'
title: RUNX3 attenuates beta-catenin/T cell factors in intestinal tumorigenesis.
authors:
- Ito K
- Lim AC
- Salto-Tellez M
- Motoda L
- Osato M
- Chuang LS
- Lee CW
- Voon DC
- Koo JK
- Wang H
- Fukamachi H
- Ito Y
journal: Cancer Cell
year: '2008'
full_text_available: false
doi: 10.1016/j.ccr.2008.08.004
---

# RUNX3 attenuates beta-catenin/T cell factors in intestinal tumorigenesis.
**Authors:** Ito K, Lim AC, Salto-Tellez M, Motoda L, Osato M, Chuang LS, Lee CW, Voon DC, Koo JK, Wang H, Fukamachi H, Ito Y
**Journal:** Cancer Cell (2008)
**DOI:** [10.1016/j.ccr.2008.08.004](https://doi.org/10.1016/j.ccr.2008.08.004)

## Abstract

1. Cancer Cell. 2008 Sep 9;14(3):226-37. doi: 10.1016/j.ccr.2008.08.004.

RUNX3 attenuates beta-catenin/T cell factors in intestinal tumorigenesis.

Ito K(1), Lim AC, Salto-Tellez M, Motoda L, Osato M, Chuang LS, Lee CW, Voon DC, 
Koo JK, Wang H, Fukamachi H, Ito Y.

Author information:
(1)Institute of Molecular and Cell Biology, Proteos, 61 Biopolis Drive, 
Singapore 138673.

Erratum in
    Cancer Cell. 2009 Mar 3;15(3):240.

In intestinal epithelial cells, inactivation of APC, a key regulator of the Wnt 
pathway, activates beta-catenin to initiate tumorigenesis. However, other 
alterations may be involved in intestinal tumorigenesis. Here we found that 
RUNX3, a gastric tumor suppressor, forms a ternary complex with 
beta-catenin/TCF4 and attenuates Wnt signaling activity. A significant fraction 
of human sporadic colorectal adenomas and Runx3(+/-) mouse intestinal adenomas 
showed inactivation of RUNX3 without apparent beta-catenin accumulation, 
indicating that RUNX3 inactivation independently induces intestinal adenomas. In 
human colon cancers, RUNX3 is frequently inactivated with concomitant 
beta-catenin accumulation, suggesting that adenomas induced by inactivation of 
RUNX3 may progress to malignancy. Taken together, these data demonstrate that 
RUNX3 functions as a tumor suppressor by attenuating Wnt signaling.

DOI: 10.1016/j.ccr.2008.08.004
PMID: 18772112 [Indexed for MEDLINE]
